Chemical and biological properties of toxic metals and use of chelating agents for the pharmacological treatment of metal poisoning

Archives of Toxicology

Volumn 84, Issue 7, 2010, Pages 501-520

  Sinicropi, Maria Stefania ^a   Amantea, Diana ^a   Caruso, Anna ^a   Saturnino, Carmela ^b  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Arsenic; Cadmium; Chelating agents; Chromium; Lead; Mercury; Metal poisoning; Nickel

Indexed keywords

ACTIVATED CARBON; CADMIUM; CALCIUM; CALMODULIN; CERULOPLASMIN; CHELATE; CHELATING AGENT; CHROMIUM; COPPER; DIMERCAPROL; DITHIOCARBAMIC ACID; EDETATE CALCIUM DISODIUM; EDETIC ACID; ELEMENT; FERRITIN; INORGANIC COMPOUND; IRON; LEAD; MERCURY; METAL; METALLOTHIONEIN; NICKEL; ORGANIC COMPOUND; PENICILLAMINE; PROTEIN; SILVER; SUCCIMER; TRANSFERRIN; UNINDEXED DRUG; ZINC;

ARSENIC POISONING; BINDING AFFINITY; BRAIN DISEASE; CADMIUM POISONING; CENTRAL NERVOUS SYSTEM FUNCTION; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; DRUG ERUPTION; FEVER; GLOMERULONEPHRITIS; HEAVY METAL POISONING; HEMATOPOIESIS; HUMAN; INDUSTRIALIZATION; INTOXICATION; KIDNEY FUNCTION; LEAD POISONING; LEUKOPENIA; LIVER FUNCTION; MERCURIALISM; METAL BINDING; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SIDE EFFECT; THROMBOCYTOPENIA;

CHELATING AGENTS; HUMANS; METALS;

EID: 77955652999     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-010-0544-6     Document Type: Review

References (171)

1. Akay C, Thomas C III, Gazitt Y (2004) Arsenic trioxide and paclitaxel induce apoptosis by different mechanisms. Cell Cycle 3:324-334
2. Åkesson A, Lundh T, Vahter M, Bjellerup P, Lidfedt J, Nerbrand C, Samsioe G, Strömberg U, Skerfving S (2005) Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect 113:1627-1631
3. Åkesson A, Bjellerup P, Lundh T, Lidfeldt J, Nerbrand C, Samsioe G, Skerfving S, Vahter M (2006) Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect 114:830-834
4. Andersen O (1999) Principles and recent developments in chelation treatment of metal intoxication. Chem Rev 99:2683-2710
5. Andersen O, Aaseth J (2002) Molecular mechanisms of in vivo metal chelation: implications for clinical treatment of metal intoxications. Environ Health Perspect 110(Suppl 5):887-890
6. Antman Karen H (2001) The history of arsenic trioxide in cancer therapy. Oncologist 6(2):1-2
7. Aposhian HV, Aposhian MM (2006) Arsenic toxicology: Wve questions. Chem Res Toxicol 19:1-15
8. Aposhian HV, Maiorino RM, Gonzales-Ramirez D, Zuniga-Charles M, Xu Z, Hrlbut KM, Junco-Munoz P, Dart RC, Aposhian MM (1995) Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology 97:23-38
9. Aposhian HV, Zakharyan RA, Avram MD, Sampayo-Reyes A, Wollenberg ML (2004) A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol Appl Pharmacol 198:327-335
10. ATSDR (1999) Toxicological profile for cadmium (update). Agency for Toxic Substances and Disease Registry. Atlanta, Georgia, pp 1-397
11. ATSDR (2000) Toxicological profile for chromium (Wnal report), NTIS Accession No PB2000-108022. Agency for Toxic Substances and Disease Registry, Atlanta, GA, p 461
12. ATSDR (2007) ToxFAQs for arsenic. Agency for Toxic Substances and Disease Registry. (Accessed November 2009, at http://www.atsdr.cdc.gov/tfacts2.html)
13. ATSDR (Agency for Toxic Substances and Disease Registry) (1988) Toxicological profile for nickel. Atlanta, GA, USA: ATSDR/U.S. Public Health Service, ATSDR/TP-88/19
14. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG (2002) Citotoxiciy and oxidative mechanisms of different forms of chromium. Toxicology 180:5-22
15. Bakir F, Damluji SF, Amin-Zaki L, Murtadha M, Khalidi A, al- Rawi NY et al (1973) Methylmercury poisoning. Iraq Sci 181:230-241
16. Bakir F, Rustam H, Tikriti S, Al-Damluji SF, Shihristani H (1980) Clinical and epidemiological aspects of methylmercury poisoning. Postgrad Med J 56:1-10
17. Baselt RC (1988) Biological monitoring methods for industrial chemicals, 2nd edn. PSG Publishing Co, Littleton Baum CR (1999) Treatment of mercury intoxication. Curr Opin Pediatr 11:265-268
18. Berglund M, Kesson AA, Bjellerup P, Vahter M (2000) Metal-bone interactions. Toxicol Lett 112-113:219-225
19. Bernard A (2008) Biomarkers of metal toxicity in population studies: research potential and interpretation issues. J Toxicol Environ Health Part A 71:1259-1265
20. Bertolero F, Pozzi G, Sabbioni E, SaYotti U (1987) Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation. Carcinogenesis 8:803-808
21. Beyersmann D, Hartwig A (2008) Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch Toxicol 82:493-512
22. Bhattacharyya MH (2009) Cadmium osteotoxicity in experimental animals: mechanisms and relationship to human exposures. Toxicol Appl Pharmacol 238:258-265
23. Bigham M, Copes R (2005) Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease. Drug Saf 28:89-101
24. Bradberry S, Vale A (2009) Dimercaptosuccinic acid (succimer; DMSA) in organic lead poisoning. Clin Toxicol 47:617-631
25. Bradman A, Eskenazi B, Sutton P, Athanasoulis M, Goldman LR (2001) Iron deficiency associated with higher blood lead in children living in contaminated environments. Environ Health Perspect 109(10):1079-1084
26. Brodkin E, Copes R, Mattman A, Kennedy J, Kling R, Yassi A (2007) Lead and mercury exposures: interpretation and action. CMAJ 176(1):59-63
27. Brooks WE (2008) Minerals yearbook 2007: arsenic. United States Geological Survey. http://minerals.er.usgs.gov/minerals/pubs/commodity/arsenic/ myb1-2007-arsen.pdf
28. Buchet JP, Lauwerys R (1988) Role of thiols in the in vitro methylation of inorganic arsenic by rat liver cytosol. Biochem Pharmacol 37:3149-3153
29. Buchet JP, Lauwerys R, Roels H, Bernard A, Bruaux P, Claeys F, Ducoffre G, de Plaen P, Staessen J, Amery A, Lijnen P, Thijs L, Rondia D, Sartor F, Saint Remy A, Nick L (1990) Renal effects of cadmium body burden of the general population. Lancet 336:699-702
30. Büdinger L, Hertl M (2000) Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview. Allergy 55(2):108-115
31. Cebrián ME, Albores A, Aguilar M, Blakely E (1983) Chronic arsenic poisoning in the north of Mexico. Hum Toxicol 2(1):121-133
32. Centeno JA, Mullick FG, Martinez L, Page NP, Gibb H, Longfellow D, Thompson C, Ladich ER (2002) Pathology related to chronic arsenic exposure. Environ Health Perspect 110:883-886
33. Cernichiari E, Brewer R, Myers GJ, Marsh DO, Lapham LW, Cox C et al (1995) Monitoring methylmercury during pregnancy: maternal hair predicts fetal brain exposure. Neurotoxicology 16:705-710
34. Chen L, Lei L, Jin T, Nordberg M, Nordberg GF (2006) Plasma etallothionein antibody, urinary cadmium, and renal dysfunction in a Chinese type 2 diabetic population. Diabetes Care 29:2682-2687
35. Cheney K, Gumbiner C, Benson B et al (1995) Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine. Clin Toxicol 33:61-66
36. Clarkson TW, Magos L, Myers GJ (2003) The toxicology of mercurycurrent exposures and clinical manifestations. N Engl J Med 349:1731-1737
37. Cohen SM, Arnold LL, Eldan M, Lewis AS, Beck BD (2006) Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit Rev Toxicol 36:99-133
38. Coogan TP, Squibb KS, Motz J, Kinney PL, Costa M (1991) Distribution of chromium within cells of the blood. Toxicol Appl Pharmacol 108:157-166
39. Costa M (1997) Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Crit Rev Toxicol 27(5):431-442
40. Cronin Joseph R (2004) The chromium controversy. Altern Complement Ther 10(1):39-42
41. Danielli JF, Danielli M, Fraser JB, Mitchell PD, Owen LN, Shaw G (1947) BAL-INTRAV: a new non-toxic thiol for intravenous injection in arsenical poisoning: 1. Biological observations. 2. Chemical observations. Biochem J 41(3):325-333
42. Das KK, Das SN, Dhundasi SA (2008) Nickel, its adverse health effects and oxidative stress. Ind J Med Res 128:412-425
43. De Flora S, Wetterhahn KE (1989) Mechanisms of chromium metabolism and genotoxicity. Life Chem Rep 7:169-244
44. De Flora S, Bagnasco M, Serra D, Zanacchi P (1990) Genotoxicity of chromium compounds. A review. Mutat Res 238:99-172
45. Denkhaus E, Salnikow K (2002) Nickel essentiality, toxicity, and arcinogenicity. Crit Rev Oncol Hematol 42:35-56
46. DHHS, US Department of Health and Human Services (2009) Mercury levels in commercial Wsh and shellfih. Washington (DC). Available: http://www.cfsan.fda. gov/~frf/sea-mehg.html (updated 05/07/2009; accessed 04/11/2009)
47. Duffus JH (2002) Heavy metals-a meaningless term? (IUPAC technical report). Pure Appl Chem 74(5):793-807
48. El-Ashmawy IM, Youssef SA (1999) The antagonistic effect of chlorpromazine on cadmium toxicity. Toxicol Appl Pharmacol 161:34-39
49. Emsley J (2001) Chromium. Nature's building blocks: an A-Z guide to the elements. Oxford University Press, Oxford, pp 495-498
50. Enterline PE, Henderson VL, Marsh GM (1987) Exposure to arsenic and respiratory cancer. A reanalysis. Am J Epidemiol 125:929-938
51. Environmental Protection Agency (EPA) (1986) Health assessment document for nickel and nickel compounds, Research Triangle Park, NC: Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, EPA-600/8-83-012F. NTIS PB86-232212
52. Environmental Protection Agency (EPA) (1999) U.S. integrated risk information system (IRIS) on arsenic. National Center for Environmental Assessment, Office of Research and Development, Washington, DC
53. Environmental Protection Agency (EPA) (2009) Table of products that may contain mercury and recommended management options. http://www.epa.gov/osw/ hazard/tsd/mercury/con-prod.htm
54. European Commission (EC) (2004) Scientific committee on toxicity, ecotoxicity and the environment (CSTEE). Opinion on the results of the risk assessment of: cadmium metal human health (CASNo.: 7440-43-9 EINECS-no.: 231-152-8), cadmium oxide human health (CAS-No.: 1306-19-0 EINECS-no.: 215-146-2)
55. European Food Safety Authority (EFSA) (2009) EFSA sets lower tolerable intake level for cadmium in food (http://www.efsa.europa.eu/EFSA/efsa-locale- 1178620753812-1211902396263.htm)
56. European Union Risk Assessment Report: cadmium oxide and cadmium metal, EUROPEAN COMMUNITIES (2007), European Chemicals Bureau, http://www.chem.unep.ch/ Pb-and-Cd/SR/IGO/070928%20UNEP%20Cadmium-ENV-DG-ENTR-draft.pdf
57. Everett CJ, Frithsen IL (2008) Association of urinary cadmium and myocardial infarction. Environ Res 106:284-286
58. Food and Drug Administration (2007) U.S. FDA warns again about arsenic in mineral water: Washington, DC, March 24. (Accessed November, 2009 at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108875.htm)
59. Goering PL, Klaassen CD (1983) Altered subcellular distribution of cadmium following cadmium pretreatment: possible mechanism of tolerance to cadmium-induced lethality. Toxicol Appl Pharmacol 70:195-203
60. Goldoni M, Caglieri A, Poli D, Vettori MV, Corradi M, Apostoli P, Mutti A (2006) Determination of hexavalent chromium in exhaled breath condensate and environmental air among chrome plating workers. Anal Chim Acta 562(2):229-235
61. Guzzi GP, La Porta CAM (2008) Molecular mechanisms triggered by mercury. Toxicology 244:1-12
62. HA OS (2006) Occupational safety and health administration, Department of Labor. Occupational exposure to hexavalent chromium. Final rule. Fed Regist 71:10099-10385
63. Hagino N, Kono M (1955) A study on the cause of Itai-itai-disease. Proceedings of the 17th meeting of the Japanese society of clinical surgeons (in Japanese)
64. Heath LM, Soole KL, McLaughlin ML, McEwan GT, Edwards JW (2003) Toxicity of environmental lead and the influence of intestinal absorption in children. Rev Environ Health 18(4):231-250
65. Henretig FM, Karl SR, Weintraub WH (1983) Severe iron poisoning treated with enteral and intravenous deferoxamine. Ann Emerg Med 12:306-309
66. Hertz-Picciotto I, Smith AH (1993) Observations on the dose response curve for arsenic exposure and lung cancer. Scand J Work Environ Health 19:217-226
67. Hotz P, Buchet JP, Bernard A, Lison D, Lauwerys R (1999) Renal effects of low-level environmental cadmium exposure: 5-year follow-up of a subcohort from the Cadmibel study. Lancet 354:1508-1513
68. Hu H (1998) Bone lead as a new biologic marker of lead dose: recent Wndings and implications for public health. Environ Health Perspect 106(4):961-967
69. Hu H, Shih R, Rothenberg S, Schwartz BS (2007) The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect 115(3):455-462
70. Hughes MF (2002) Arsenic toxicity and potential mechanisms of action. Toxicol Lett 133:1-16
71. IARC (1987) Monographs on the evaluation of carcinogenic risks to humans. overall evaluations of carcinogenicity: an updating of IARC monographs. Arsenic Arsenic Compd 1-42(1.7):100-106
72. IARC (1990) IARC monographs on the evaluation of carcinogenic risks to humans. Chromium, nickel and welding, vol 49 at http://monographs.iarc.fr/ENG/ Monographs/vol49/volume49.pdf
73. IARC (2004) Monographs on the evaluation of carcinogenic risks to humans. Some drinking-water disinfectants and contaminants, including arsenic 84:41-267
74. Iavicoli I, Fontana L, Bargamanschi A (2009) The effects of metals as endocrine disruptors. J Toxicol Environ Health Part B 12:206-223
75. Järup L (2003) Hazards of heavy metal contamination. Br Med Bull 68:167-182
76. Järup L, Åkesson A (2009) Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238:201-208
77. Järup L, Rogenfelt A, Elinder CG, Nogawa K, Kjellstrom T (1983) Biological half-time of cadmium in the blood of workers after cessation of exposure. Scand J Work Environ Health 9:327-331
78. Järup L, Berglund M, Elinder CG, Nordberg G, Vahter M (1998) Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand J Work Environ Health 24(1):1-51
79. Järup L, Hellström L, Alfvén T, Carlsson MD, Grubb A, Persson B, Pettersson C, Spang G, Schütz A, Elinder CG (2000) Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med 57:668-672
80. Kalia K, Flora SJS (2005) Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. J Occup Health 47:1-21
81. Kasprzak KS, Sunderman FW, Salnikow K (2003) Nickel carcinogenesis. Mutat Res 533:67-97
82. Katz SA, Salem H (1993) The toxicology of chromium with respect to its chemical speciation: a review. J Appl Toxicol 13(3):217-224
83. Kern M, Wisniewski M, Cabell L, Audesirk G (2000) Inorganic lead and calcium interact positively in activation of calmodulin. Neurotoxicology 21(3):353-363
84. Klaassen CD, Liu J, Diwan BA (2009) Metallothionein protection of cadmium toxicity. Toxicol Appl Pharmacol 238(3):215-220
85. Kobayashi E, Suwazono Y, Honda R, Dochi M, Nishijo M, Kido T, Nakagawa H (2008) Changes in renal tubular and glomerular functions and biological acid-base balance after soil replacement in Cd-polluted rice paddies calculated with a general linear mixed model. Biol Trace Elem Res 124:164-172
86. Kostial K (1986) Cadmium. In: Mertz W (ed) Trace elements in human and animal nutrition, vol 2. Academic Press, Orlando, pp 319-345
87. Kotam J, Stasicka Z (2000) Chromium occurrence in the environment and methods of its speciation. Environ Pollut 107(3):263-283
88. Kumpulainen JT (1992) Chromium content of foods and diets. Biol Trace Elem Res 32:9-18
89. Labbé RF, Vreman HJ, Stevenson DK (1999) Zinc protoporphyrin: a metabolite with a mission. Clin Chem 45(12):2060-2072
90. Lamborg CH, Fitzgerald WF, O'Donnell J, Torgerson T (2002) A nonsteady state compartmental model of global-scale mercury biogeochemistry with interhemispheric atmospheric gradients. Geochim Cosmochim Acta 66:1105-1118
91. Lerman SA, Clarkson TW, Gerson RJ (1983) Arsenic uptake and metabolism by liver cells is dependent on arsenic oxidation state. Chem Biol Interact 45:401-406
92. Levina A, Lay PA (2005) Mechanistic studies of relevance to the biological activities of chromium. Coord Chem Rev 249:281-298
93. Levina A, Lay PA (2008) Chemical properties and toxicity of Chromium( III) nutritional supplements. Chem Res Toxicol 21:563-571
94. Levina A, Codd R, Dillon CT, Lay PA (2003) Chromium in biology: toxicology and nutritional aspects. Prog Inorg Chem 51:145-250
95. Lindqvist O, Johansson K, Aastrup M, Andersson A, Bringmark L, Hovsenius G, Hakanson L, Iverfeldt A, Meili M, Timm B (1991) Mercury in the Swedish environment-recent research on causes, consequences and corrective methods. Water Air Soil Pollut 55:1-261
96. Liu J, Goyer R, Waalkes MP (2007a) A toxic effects of metals. In: Klaassen CD (ed) Casarett and Doull's toxicology-the basic science of poisons, 7th edn. McGraw Hill, New York, pp 931-979
97. Liu J, Cheng ML, Yang Q, Shan KR, Shen J, Zhou Y, Zhang X, Dill AL, Waalkes MP (2007b) Blood metallothionein transcript as a biomarker for metal sensitivity: low blood metallothionein transcripts in arsenicosis patients from Guizhou, China. Environ Health Perspect 115:1101-1106
98. Lynes MA, Kang YJ, Sensi SL, Perdrizet GA, Hightower LE (2007) Heavy metal ions in normal physiology, toxic stress, and cytoprotection. Ann N Y Acad Sci 1113:159-172
99. Mandal BK, Ogra Y, Anzai K, Suzuki KT (2004) Speciation of arsenic in biological samples. Toxicol Appl Pharmacol 198:307-318
100. Mann KV, Picciotti MA, Spevack TA et al (1989) Management of acute iron overdose. Clin Pharm 8:428-440
101. Martelli A, Rousselet E, Dycke C, Bouron A, Moulis JM (2006) Cadmium toxicity in animal cells by interference with essential metals. Biochimie 88:1807-1814
102. Martin SF, Merfort I, Thierse HJ (2006) Interactions of chemicals and metal ions with proteins and role for immune responses. Mini Rev Med Chem 6(3):247-255
103. Mason RP, Fitzgerald WF, Morel FMM (1994) The biogeochemical ycling of elemental mercury: anthropogenic influences. Geochim Cosmochim Acta 58:3191-3198
104. Matsuno K, Kodama Y, Tsuchiya K (1991) Biological half-time and body burden of cadmium in dogs after a long-term oral administration of cadmium. Biol Trace Elem Res 29:111-123
105. McFarland RB, Reigel H (1978) Chronic mercury poisoning from a single brief exposure. J Occup Med 20:532-534
106. Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S (2002) chanisms of action of arsenic trioxide. Cancer Res 62:3893-3903
107. Morgan LG, Usher V (1994) Health problems associated with nickel refining and use. Ann Occup Hyg 38:189-198
108. Mückter H, Liebl B, Reichl FX, Hunder G, Walther U, Fichtl B (1997) are we ready to replace dimercaprol (BAL) as an arsenic antidote? Hum Exp Toxicol 16(8):460-465
109. Muntau H, Baudo R (1992) Sources of cadmium, its distribution and turnover in the freshwater environment. IARC 118:133-148
110. Murata K, Iwata T, Dakeishi M, Karita K (2009) Lead toxicity:does the critical level of lead resulting in adverse effects differ between adults and children? J Occup Health 51(1):1-12
111. Nielsen FH (1998) Ultratrace elements in nutrition: current knowledge and speculation. J Trace Elements Exp Med 11:251-274
112. Nolan CV, Shaikh ZA (1992) Lead nephrotoxicity and associated disorders: biochemical mechanisms. Toxicology 73:127-146
113. Nordberg GF, Goyer R, Nordberg M (1975) Comparative toxicity of admium metallothionein and cadmium chloride on mouse kidney. Arch Pathol 99:192-197
114. Nordberg M, Jin T, Nordberg GF (1992) Cadmium, metallothionein and renal tubular toxicity. IARC 118:293-297
115. O'Brien TJ, Ceryak S, Patierno SR (2003) Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res 533:3-36
116. O'Flaherty EJ (1993) Physiologically based models for boneseeking elements. IV. Kinetics of lead disposition in humans. Toxicol Appl Pharmacol 118(1):16-29
117. Olsson IM, Bensryd I, Lundh T, Ottosson H, Skerfving S, Oskarsson (2002) Cadmium in blood and urine-impact of sex, age, dietary intake, iron status, and former smoking-association of renal effects. Environ Health Perspect 110(12):1185-1190
118. Pacyna EG, Pacyna JM, Sundseth K, Munthe J, Kindbom K, Wilson S, Steenhuisen F, Maxson P (2009) Global emission of mercury to the atmosphere from anthropogenic sources in 2005 and projections to 2020. Atmos Environ. doi:10.1016/j.atmosenv.2009.06.009
119. Patrick L (2006) Lead toxicity, a review of the literature. Part 1: exposure, evaluation and treatment. Altern Med Rev 11(1):2-22
120. Paustenbach DJ, Panko JM, Fredrick MM, Finley BL, Proctor DM (1997) Urinary chromium as a biological marker of environmental exposure: what are the limitations? Reg Toxicol Pharmacol 26:S23-S34
121. Pearce JMS (2007) Burton's line in lead poisoning. Eur Neurol 57(2):118-119
122. Peters RA, Stocken LA, Thompson RHS (1945) British Anti-Lewisite (BAL). Nature 156:616-619
123. Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Aposhian HV (2000) Monomethylarsonous acid (MMAIII) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 163:203-207
124. Petrick JS, Jagadish B, Mash EA, Aposhian HV (2001) Monomethylarsonous acid (MMAIII) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol 14:651-656
125. Powell JJ, Burden TJ, Greenfield SM, Taylor PD, Thompson RPH (1999) Urinary excretion of essential metal following intravenous calcium disodium edentate: an estimate of free zinc and zinc status in man. J Inorg Biochem 75:159-165
126. Rabinowitz MB (1991) Toxicokinetics of bone lead. Environ Health Perspect 91:33-37
127. Rabinowitz MB, Wetherill GW, Kopple JD (1973) Lead metabolism in the normal human: stable isotope studies. Science 182(113):725-727
128. Ragsdale SW (2009) Nickel-based enzyme systems. J Biol Chem 284:18571-18575
129. RC IA (1993) Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. International agency for research on cancer monographs on the evaluation of carcinogenic risks to humans. IARC Scientific Publications, Lyon, pp 1-415
130. Rettmer RL, Carlson TH, Origenes ML, Jack RM, Labb RF (1999) Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency. Pediatrics 104(3):e37
131. Risher JF, Amler SN (2005) Mercury exposure: evaluation and intervention the inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning. Neurotoxicology 26:691-699
132. Roussel AM, Andriollo-Sanchez M, Ferry M, Bryden NA, Anderson RA (2007) Food chromium content, dietary chromium intake, related biological variables in French free-living elderly. Br J Nutr 98(2):326-331
133. Saha JC, Dikshit AK, Bandyopadhyay M, Saha KC (1999) A review of arsenic poisoning and its effects on human health. Crit Rev Environ Sci Technol 29:281-313
134. Salnikow K, Zhitkovich A (2008) Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 21(1):28-44
135. Saper RB, Kales SN, Paquin J et al (2004) Heavy metal content of Ayurvedic herbal medicine products. JAMA 292:2868-2873
136. Satarug S, Moore MR (2004) Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect 112:1099-1103
137. Sauer JM, Waalkes MP, Hooser SB, Kuester RK, McQueen CA, Sipes IG (1997) Suppression of Kupffer cell function prevents cadmium induced hepatocellular necrosis in the male Sprague-Dawley rat. Toxicology 121:155-164
138. Schutte R, Nawrot TS, Richart T, Thijs L, Vanderschueren D, Kuznetsova T, Van Hecke E, Roels HA, Staessen JA (2008a) Bone resorption and environmental exposure to cadmium in women: a population study. Environ Health Perspect 116:777-783
139. Schutte R, Nawrot T, Richart T, Thijs L, Roels HA, Van Bortel LM, Struijker-Boudier H, Staessen JA (2008b) Arterial structure and function and environmental exposure to cadmium. Occup Environ Med 65:412-419 (Pubitemid 351775802)
140. Shannon M, Graef J, Lovejoy FH (1988) EYcacy and toxicity of D-penicillamine in low level lead poisoning. J Pediatr 112:799-804
141. Shen Y, Shen ZX, Yan H, Chen J, Zeng XY, Li JM, Li XS, Wu W, Xiong SM, Zhao WL, Tang W, Wu F, Liu YF, Niu C, Wang ZY, Chen SJ, Chen Z (2001) Studies on the clinical eYcacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage. Leukemia 15:735-741
142. Snow ET (1992) Metal carcinogenesis: mechanistic implications. Pharmacol Ther 53(1):31-65
143. Stallings D, Vincent JB (2006) Chromium: a case study in how not to perform nutritional research. Curr Top Nutraceut Res 4:89-112
144. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74:289-299
145. Tallman MS (2007) Treatment of relapsed or refractory acute promyelocytic leukemia. Best Pract Res Clin Haematol 20:57-65
146. Tchounwou PB, Patlolla AK, Centeno JA (2003) Carcinogenic and ystemic health effects associated with arsenic exposure - a critical review. Toxicol Pathol 31:575-588
147. Tchounwou PB, Centeno JA, Patlolla AK (2004) Arsenic toxicity, mutagenesis, and carcinogenesis - a health risk assessment and management approach. Mol Cell Biochem 255:47-55
148. Thévenod F (2009) Cadmium and cellular signalling cascades: to be or not to be? Toxicol Appl Pharmacol 238(3):221-239
149. Thomas DJ, Styblo M, Lin S (2001) The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 176:127-144
150. Thompson J, Bannigan J (2008) Cadmium: toxic effects on the reproductive system and the embryo. Reprod Toxicol 25:304-315
151. Tseng CH (2005) Blackfoot disease and arsenic: a never-ending story. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 23(1):55-74
152. Tsuda T, Yorifuji T, Takao S, Miyai M, Babazono A (2009) Minamata disease: catastrophic poisoning due to a failed public health response. J Public Healthy Policy 30:54-67
153. Ullrich SM, Tanton TW, Abdrashitova SA (2001) Mercury in the aquatic environment: a review of factors affecting methylation. Crit Rev Environ Sci Technol 31:241-293
154. Vahidnia A, Van der Voet GB, de WolV FA (2007) Arsenic neurotoxicity - a review. Hum Exp Toxicol 26:823-832
155. Vas J, Monestier M (2008) Immunology of mercury. Ann NY Acad Sci 1143:240-267
156. Vasak M (2005) Advances in metallothionein structure and functions. J Trace Elem Med Biol 19:13-17
157. Vroom FQ, Greer M (1972) Mercury vapour intoxication brain 95:305-318
158. Waalkes MP (2003) Cadmium carcinogenesis. Mutat Res 533:107-120
159. Wang C, Brown S, Bhattacharyya MH (1994) Effect of cadmium on bone calcium and 45Ca in mouse dams on a calcium-deficient diet: evidence of Itai-Itai-like syndrome. Toxicol Appl Pharmacol 127:320-330
160. Washko P, Cousins RJ (1977) Role of dietary calcium and calcium binding protein in cadmium toxicity in rats. J Nutr 107(5):920-928
161. Weiss B, Clarkson TW, Simon W (2002) Silent latency periods in methylmercury poisoning and in neurodegenerative disease. Environ Health Perspect 110(5):851-854
162. White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, Virgolini M, Rossi-George A, Lasley SM, Qian YC, Riyaz Basha MD (2007) New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol 225:1-27
163. WHO (1991) Environmental health criteria 118. Inorganic mercury. International program on chemical safety. World Health Organization, Geneva
164. WHO (1992a) Environmental Health Criteria 134. Cadmium, Geneva
165. WHO (1992) Environmental Health Criteria 135. Cadmium-environmental aspects, Geneva
166. Wise JP Sr, Wise SS, Little JE (2002) The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells. Mut Res 517:221-229
167. Yager JW, Wiencke JK (1997) Inhibition of poly(ADP-ribose) polymerase by arsenite. Mutat Res 386:345-351
168. Yeh S, How SW, Lin CS (1968) Arsenical cancer of skin. Histologic study with special reference to Bowen's disease. Cancer 21(2):312-339
169. Zalups RK (2000) Molecular interactions with mercury in the kidney. Pharmacol Rev 52:113-143
170. Zhitkovich A (2002) Chromium: exposure, toxicity and biomonitoring approaches. In: Wilson SH, Suk WA (eds) Biomarkers of environmentally associated disease: technologies, Concepts, and perspectives. CRC Press LLC, New York, pp 269-287
171. Zhitkovich A (2005) Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). Chem Res Toxicol 18:3-11